| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.006 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |